← All organizations

Shanghai Longyao Biotechnology Inc., Ltd.

Government

Also known as: Shanghai Longyao Bio-Tech Co., Ltd. | Shanghai Longyao Biotechnology Inc., Ltd.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 25, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (4 distinct, 8 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (11)

NCT06364852CollaboratorPhase 1Dec 25, 2021
NCT06279611Lead sponsorPhase 1Dec 25, 2021
NCT04977193Lead sponsorEarly Phase 1Nov 1, 2021
NCT04966143Lead sponsorEarly Phase 1Aug 1, 2021
NCT04169932Study chairEarly Phase 1Nov 22, 2019
NCT04169932Lead sponsorEarly Phase 1Nov 22, 2019
NCT04166838Study chairEarly Phase 1Nov 8, 2019
NCT04166838Lead sponsorEarly Phase 1Nov 8, 2019
NCT03576807Lead sponsorPhase 1Apr 4, 2018
NCT03207178Lead sponsorPhase 1/Phase 2Mar 1, 2017
NCT03207178Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2017

Details

Last known activity: Dec 25, 2021